داء كيكوشي و يدعى أيضاً داء كيكوشي- فوجيموتو، أو التهاب العقـد اللمفاويـة المنخـر
مرض نادر الحدوث، و مجهول السبب، و محدد لنفسه. وردت أول التقارير في الأدب الطبـي
عن هذا المرض من اليابان عام 1972 و بشكل منفصل من قبل طبيبـين همـا كيكوشـي و
فوجيموتو. و تبعتها تقارير لحالات مشابهة من مناطق أخرى في العالم. سجلنا تقريـرا لأول
حالة بداء كيكوشي- فوجيموتو في سورية بمشفى المواساة الجامعي، عند رجل بعمـر 38
سنة، و قد تظاهر المرض بحرارة مزمنة مجهولة السبب منذ أكثر من شهرين مع ضخامات
عقد لمفاوية متعددة. قمنا بمراجعة الأدب الطبـي و تلخـيص أهـم الخـصائص الـسريرية
و الموجودات المخبرية و النسيجية المميزة لداء كيكوشي- فوجيموتو.
Kikuchi’s disease called also Kikuchi- Fujimoto’s disease or Histiocytic
necrotizing lymphadenitis is a rare entity. It is a self-limiting process of
unknown etiology first reported in Japanese literature separately by
Kikuchi and Fujimoto in 1972. Then similar cases have subsequently been
reported throughout the world.
We reported a case of Kikuchi's disease in a. 38-year-old man presenting
with generalized lymphadenopathy and persistent fever throughout more
than 2 months. It’s the first case was diagnosed in Al muwasat University
Hospital in Syria.
We reviewed the literature to summarize and report the most common
clinical, laboratory and histology characteristics of Kikuchi- Fujimoto’s
disease.
References used
Dorfman RF: Histiocytic necrotizing lymphadenitis of Kikuchi and Fujimoto. Arch Pathol Lab Med 111:1026-1029, 1987
Pileri S, Kikuchi M, Helbron D, et al: Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Archives (A) Pathol Anat Histol 395:257-271, 1982
Al-Nazer MA; Al-Hadad AM; Al-Aithan SA; Al-Salem AH; Al-Faraj AA; Al-Saeed HH:Kukuchi-Fujimito disease.Saudi Med J 2002 Apr;23 (4):405
Atherosclerosis and infectious diseases are the most common cause. Ultrasonography, computerized
tomography, and arteriography are used to make the diagnosis and treatment is achieved by
surgery or percutaneous techniques.
We herein report a SMA a
To combat COVID-19, both clinicians and scientists need to digest the vast amount of relevant biomedical knowledge in literature to understand the disease mechanism and the related biological functions. We have developed a novel and comprehensive kno
P53 is the guardian of genome from any alteration, its gene is called tumor suppressor gene . p53 checks
any alteration in cell cycle ,and if the alteration happened p53 resolves or shares in activation proteins
important in resolving , if the cell
The benign vascular tumors are the most common of benign soft tissue neoplasms,
majority of them appears in the skin and mucosa, but they are rare in the skeletal muscles,
the difficulties during the management of these tumors are pre-operative dia
Integrating knowledge into text is a promising way to enrich text representation, especially in the medical field. However, undifferentiated knowledge not only confuses the text representation but also imports unexpected noises. In this paper, to all